Page last updated: 2024-08-16

rivastigmine and Cardiovascular Diseases

rivastigmine has been researched along with Cardiovascular Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaushik, V; Mikobi, E; Raji, MA; Smith, ST1
Kinnair, D; Machili, C; Prettyman, R; Van Diepen, E1
Erkinjuntti, T; Feldman, H; Gauthier, S; Rockwood, K; Román, G1

Reviews

1 review(s) available for rivastigmine and Cardiovascular Diseases

ArticleYear
Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease.
    American journal of Alzheimer's disease and other dementias, 2018, Volume: 33, Issue:2

    Topics: Alzheimer Disease; Cardiovascular Diseases; Cholinesterase Inhibitors; Comorbidity; Donepezil; Galantamine; Polypharmacy; Rivastigmine

2018

Other Studies

2 other study(ies) available for rivastigmine and Cardiovascular Diseases

ArticleYear
Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability.
    International journal of geriatric psychiatry, 2011, Volume: 26, Issue:3

    Topics: Alzheimer Disease; Cardiovascular Diseases; Cholinesterase Inhibitors; Donepezil; Galantamine; Humans; Indans; Multivariate Analysis; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine

2011
Emerging therapies for vascular dementia and vascular cognitive impairment.
    Stroke, 2004, Volume: 35, Issue:4

    Topics: Carbamates; Cardiovascular Diseases; Cerebrovascular Disorders; Cholinesterase Inhibitors; Cognition Disorders; Controlled Clinical Trials as Topic; Dementia, Vascular; Donepezil; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Risk Factors; Rivastigmine; Stroke; Terminology as Topic

2004